The company portfolio includes a variety of drug delivery and drug development R&D programs in different development stages. Company resources (both workforce and budget) are limited.

The Company’s strategy is to use the drug delivery business to finance internal drug development and, at the same time, to preserve the highest value of the Company’s portfolio. Drug development programs could be developed internally or outsourced. Other goals include (1) maximum available throughput of various types of projects and (2) maximum resource utilization. 

Based on ORBee Consulting modeling analysis, the following benefits were achieved: